Status:

COMPLETED

Study of Gut Microbiome and Colorectal Tumors

Lead Sponsor:

NYU Langone Health

Conditions:

Serrated Polyp

Hyperplastic Polyp

Eligibility:

All Genders

18+ years

Brief Summary

Gut microbiota were assessed in 540 colonoscopy-screened adults by 16S rRNA gene sequencing of stool samples. Investigators compared gut microbiota diversity, overall composition, and normalized taxon...

Detailed Description

Colorectal cancer is a heterogeneous disease arising from at least two precursors-the conventional adenoma (CA) and the serrated polyp. A relationship between the human gut microbiota and colorectal c...

Eligibility Criteria

Inclusion

  • Both men and women who have visited a gastroenterologist or surgeon, aged 18 or older will be included in this study.
  • Both men and women residents in the United States, aged 18 or older will be included in this study.

Exclusion

  • Women who are pregnant will be excluded from participating in this study
  • Subjects on ongoing antibiotic therapy will be excluded from participating in this study.

Key Trial Info

Start Date :

November 23 2011

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 25 2015

Estimated Enrollment :

540 Patients enrolled

Trial Details

Trial ID

NCT03297996

Start Date

November 23 2011

End Date

April 25 2015

Last Update

September 29 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

New York University School of Medicine

New York, New York, United States, 10016